How Will Skyrizi and Rinvoq Sales Aid AbbVie's Upcoming Q2 Results?
unknown
📅 Published: 2025-07-08 12:27
📰 Source: Yahoo
📝 Words: 18
📝 Article Content
ABBV leans on Skyrizi and Rinvoq sales strength to offset Humira's decline ahead of its Q2 earnings report.
📄 Summary
ABBV leans on Skyrizi and Rinvoq sales strength to offset Humira's decline ahead of its Q2 earnings report.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-07-08 15:40:09
Updated At:
2025-07-08 15:40:09
Scraping Job ID:
N/A
Stock Mentions:
ABBV - AbbVie Inc.
Relevance: N/A